North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Product Description
In-house Standards
AI Product Description
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Ritonavir (CAS <strong>155213-67-5</strong>) is a potent HIV protease inhibitor synthesized via chiral catalysis. Its molecular formula is <strong>C<sub>37</sub>H<sub>48</sub>N<sub>6</sub>O<sub>5</sub>S<sub>2</sub></strong>, serving as a critical pharmacological agent in antiretroviral therapy.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical Manufacturing:</strong> Primary API for HIV/AIDS treatment regimens.</li>
<li><strong>Boosting Agent:</strong> Enhances plasma concentrations of co-administered protease inhibitors.</li>
<li><strong>Research & Development:</strong> Standard reference material for antiviral efficacy studies.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly contraindicated with specific CYP3A substrates due to severe drug-drug interaction risks. Requires storage in sealed, light-resistant containers at controlled room temperature to maintain chemical stability.</p>